Literature DB >> 9282281

Omeprazole induces a long-term clinical remission of protein-losing gastropathy of Ménétrier's disease.

S D Ladas1, P S Tassios, H C Malamou, D P Protopapa, S A Raptis.   

Abstract

We report a patient with Ménétrier's disease presenting with extensive subcutaneous oedema, ascites and pleural effusion due to hypoalbuminaemia. Gastric secretory studies showed no free basal and stimulated acid secretion. The gastric juice contained significant amounts of albumin (0.2 g/dl) and immunoglobulin G (IgG) (1.11 mg/dl), corresponding to an estimated daily loss of 9.7 g and 45 mg, respectively. Protein-losing gastropathy was initially unsuccessfully treated with famotidine (80 mg/day) for 17 months, but a long-term (25 months) clinical remission was subsequently achieved with omeprazole (20 mg/day). We suggest that excellent clinical remission of Ménétrier's disease and the associated protein-losing gastropathy may be obtained with long-term omeprazole maintenance treatment, possibly due to Helicobacter pylori suppression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282281     DOI: 10.1097/00042737-199708000-00014

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

1.  Helicobacter pylori-associated protein-losing hypertrophic gastropathy with hypercholesterolemia.

Authors:  A N Kapsoritakis; S Potamianos; E Matrella; S Koukouraki; E Oeconomaki; M Tzardi; N Karkavitsas; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

2.  Protein-Losing Enteropathy and Gastropathy.

Authors:  Brian R. Landzberg; Mark B. Pochapin
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.